Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib

NCT01432119 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Advanced Cancers

Interventions

DEVICE: SIR-Spheres
DRUG: Cetuximab
DRUG: Erlotinib
PROCEDURE: Break-Through Scan

Sponsor

M.D. Anderson Cancer Center